Greenlight Biosciences Holdings, Pbc (GRNA) SEC Filing 10-K Annual Report for the fiscal year ending Friday, December 31, 2021

Greenlight Biosciences Holdings, Pbc

CIK: 1822691 Ticker: GRNA
Cover Page - USD ($)
12 Months Ended
Dec. 31, 2021
Mar. 15, 2022
Jun. 30, 2021
Document Information [Line Items]   
Document Type10-K  
Entity Registrant NameGreenLight Biosciences Holdings, PBC  
Amendment Flagfalse  
Entity Central Index Key0001822691  
Document Annual Reporttrue  
Document Transition Reportfalse  
Current Fiscal Year End Date--12-31  
Document Period End DateDec. 31, 2021  
Document Fiscal Year Focus2021  
Document Fiscal Period FocusFY  
Entity Filer CategoryNon-accelerated Filer  
Entity Shell Companyfalse  
Entity Voluntary FilersNo  
Entity Well-known Seasoned IssuerNo  
Entity Small Businesstrue  
Entity Current Reporting StatusYes  
Entity Interactive Data CurrentYes  
Entity Emerging Growth Companytrue  
Entity Ex Transition Periodfalse  
Entity File Number001-39894  
Entity Tax Identification Number85-1914700  
Entity Incorporation, State or Country CodeDE  
Entity Address, Address Line One200 Boston Avenue  
Entity Address, City or TownMedford  
Entity Address, State or ProvinceMA  
City Area Code617  
Local Phone Number616-8188  
Entity Address, Postal Zip Code02155  
Title of 12(b) SecurityCommon stock, par value $0.0001 per share  
Trading SymbolGRNA  
Security Exchange NameNASDAQ  
Entity Common Stock, Shares Outstanding 122,839,613 
Auditor Firm ID100  
Auditor NameWithumSmith+Brown, PC  
Auditor LocationNew York, New York  
Entity Public Float  $ 193,257,000
ICFR Auditor Attestation Flagfalse  
Warrants [Member]   
Document Information [Line Items]   
Title of 12(b) SecurityWarrants, each exercisable for one share of Common Stock for $11.50 per share  
Trading SymbolGRNAW  
Security Exchange NameNASDAQ  

View differences made from one year to another to evaluate Greenlight Biosciences Holdings, Pbc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Greenlight Biosciences Holdings, Pbc.


Assess how Greenlight Biosciences Holdings, Pbc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Greenlight Biosciences Holdings, Pbc's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Cover Page
Consolidated Balance Sheets
Consolidated Balance Sheets (Parentheticals)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Stockholders' (Deficit) Equity
Consolidated Statements Of Operations
Accounting Policies, By Policy (Policies)
Commitments And Contingencies
Commitments And Contingencies - Additional Information (Details)
Description Of Organization And Business Operations
Description Of Organization And Business Operations - Additional Information (Details)
Fair Value Measurements
Fair Value Measurements (Details) - Additional Information
Fair Value Measurements (Details) - Schedule Of Assets And Liabilities At Fair Value On A Recurring Basis
Fair Value Measurements (Details) - Schedule Of Black-Scholes-Merton Model For The Warrants
Fair Value Measurements (Details) - Schedule Of Changes In The Fair Value Of Level 3 Warrant Liabilities
Fair Value Measurements (Tables)
Income Tax
Income Tax (Details) - Schedule Of Income Tax Provision
Income Tax (Details) - Summary Of Net Deferred Tax Assets
Income Tax (Details) - Summary Of The Reconciliation Of Effective Tax Rate To The Statutory Federal Income Tax Rate
Income Tax (Tables)
Income Tax - Additional Information (Details)
Initial Public Offering
Initial Public Offering - Additional Information (Details)
Private Placement
Private Placement - Additional Information (Details)
Related Party Transactions
Related Party Transactions - Additional Information (Details)
Stockholders' Equity
Stockholders' Equity - Additional Information (Details)
Subsequent Events
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details) - Schedule Of Basic And Diluted Net Income (Loss) Per Common Share
Summary Of Significant Accounting Policies (Details) - Schedule Of Class A Common Stock Subject To Possible Redemption Reflected In Condensed Consolidated Balance Sheet
Summary Of Significant Accounting Policies (Tables)
Summary Of Significant Accounting Policies - Additional Information (Details)
Warrants - Additional Information (Details)
Ticker: GRNA
CIK: 1822691
Form Type: 10-K Annual Report
Accession Number: 0001193125-22-092115
Submitted to the SEC: Thu Mar 31 2022 5:29:32 PM EST
Accepted by the SEC: Thu Mar 31 2022
Period: Friday, December 31, 2021
Industry: Biological Products No Disgnostic Substances

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: